CNBCさんのインスタグラム写真 - (CNBCInstagram)「AstraZeneca shares turned negative Wednesday after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.⁠ ⁠ The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters. The news comes as the FDA still has a late-stage clinical trial from AstraZeneca on hold in the United States. That means the company is unable to administer second doses of its two-dose vaccine regimen to U.S. participants.⁠ ⁠ A spokesperson from AstraZeneca declined to comment on the Brazilian volunteer, citing “medical confidentiality and clinical trial regulations.” The spokesperson added that ”[a]ll significant medical events are carefully assessed by trial investigators” and ”[t]hese assessments have not led to any concerns about continuation of the ongoing study.”⁠ ⁠ Oxford University, which is developing the vaccine with AstraZeneca, provided no further details on the volunteer’s death, and it’s unclear if the volunteer received the vaccine.⁠ ⁠ Full details at the link in bio.」10月22日 6時30分